These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23951517)

  • 21. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones.
    Ominsky MS; Li C; Li X; Tan HL; Lee E; Barrero M; Asuncion FJ; Dwyer D; Han CY; Vlasseros F; Samadfam R; Jolette J; Smith SY; Stolina M; Lacey DL; Simonet WS; Paszty C; Li G; Ke HZ
    J Bone Miner Res; 2011 May; 26(5):1012-21. PubMed ID: 21542004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-dependent effects of sclerostin antibody on a mouse fracture healing model.
    Cui L; Cheng H; Song C; Li C; Simonet WS; Ke HZ; Li G
    J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):178-84. PubMed ID: 23728104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endochondral fracture healing with external fixation in the Sost knockout mouse results in earlier fibrocartilage callus removal and increased bone volume fraction and strength.
    Morse A; Yu NY; Peacock L; Mikulec K; Kramer I; Kneissel M; McDonald MM; Little DG
    Bone; 2015 Feb; 71():155-63. PubMed ID: 25445453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats.
    Liu Y; Rui Y; Cheng TY; Huang S; Xu L; Meng F; Lee WY; Zhang T; Li N; Li C; Ke H; Li G
    Calcif Tissue Int; 2016 Mar; 98(3):263-74. PubMed ID: 26603303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
    Maïmoun L; Ben Bouallègue F; Gelis A; Aouinti S; Mura T; Philibert P; Souberbielle JC; Piketty M; Garnero P; Mariano-Goulart D; Fattal C
    Bone; 2019 Oct; 127():612-619. PubMed ID: 31351195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
    Morales-Santana S; Díez-Pérez A; Olmos JM; Nogués X; Sosa M; Díaz-Curiel M; Pérez-Castrillón JL; Pérez-Cano R; Torrijos A; Jodar E; Rio LD; Caeiro-Rey JR; Reyes-García R; García-Fontana B; González-Macías J; Muñoz-Torres M
    Maturitas; 2015 Dec; 82(4):402-10. PubMed ID: 26358930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.
    Amrein K; Dobnig H; Wagner D; Piswanger-Sölkner C; Pieber TR; Pilz S; Tomaschitz A; Dimai HP; Fahrleitner-Pammer A
    J Am Geriatr Soc; 2014 Jun; 62(6):1023-9. PubMed ID: 24779429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidates
.
    Jørgensen HS; Winther S; Dupont L; Bøttcher M; Rejnmark L; Hauge EM; Svensson M; Ivarsen P
    Clin Nephrol; 2018 Jul; 90(1):18-26. PubMed ID: 29701175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum sclerostin levels and metabolic bone diseases].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2013 Jun; 23(6):877-83. PubMed ID: 23719501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerostin, an emerging therapeutic target for treating osteoporosis and osteoporotic fracture: A general review.
    Suen PK; Qin L
    J Orthop Translat; 2016 Jan; 4():1-13. PubMed ID: 30035061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Atteritano M; Di Mauro E; Canale V; Bruzzese AM; Ricciardi CA; Cernaro V; Lacquaniti A; Buemi M; Santoro D
    Osteoporos Int; 2017 Feb; 28(2):577-584. PubMed ID: 27682249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased sclerostin associated with stress fracture of the third metacarpal bone in the Thoroughbred racehorse.
    Hopper N; Singer E; Henson F
    Bone Joint Res; 2018 Jan; 7(1):94-102. PubMed ID: 29363519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-IL-20 monoclonal antibody promotes bone fracture healing through regulating IL-20-mediated osteoblastogenesis.
    Hsu YH; Chiu YS; Chen WY; Huang KY; Jou IM; Wu PT; Wu CH; Chang MS
    Sci Rep; 2016 Apr; 6():24339. PubMed ID: 27075747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing.
    Agholme F; Macias B; Hamang M; Lucchesi J; Adrian MD; Kuhstoss S; Harvey A; Sato M; Aspenberg P
    J Orthop Res; 2014 Mar; 32(3):471-6. PubMed ID: 24243768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigational drugs for fracture healing: preclinical & clinical data.
    Klontzas ME; Kenanidis EI; MacFarlane RJ; Michail T; Potoupnis ME; Heliotis M; Mantalaris A; Tsiridis E
    Expert Opin Investig Drugs; 2016; 25(5):585-96. PubMed ID: 26938853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated fracture healing with teriparatide.
    Borges JL; Freitas A; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2013 Mar; 57(2):153-6. PubMed ID: 23525295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms Underlying Normal Fracture Healing and Risk Factors for Delayed Healing.
    Cheng C; Shoback D
    Curr Osteoporos Rep; 2019 Feb; 17(1):36-47. PubMed ID: 30671884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and Fractures.
    Zheng J; Maerz W; Gergei I; Kleber M; Drechsler C; Wanner C; Brandenburg V; Reppe S; Gautvik KM; Medina-Gomez C; Shevroja E; Gilly A; Park YC; Dedoussis G; Zeggini E; Lorentzon M; Henning P; Lerner UH; Nilsson KH; Movérare-Skrtic S; Baird D; Elsworth B; Falk L; Groom A; Capellini TD; Grundberg E; Nethander M; Ohlsson C; Davey Smith G; Tobias JH
    J Bone Miner Res; 2019 Oct; 34(10):1824-1836. PubMed ID: 31170332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.